HPV Testing and Pap Test Market worth $9.2 billion by 2027
The report "HPV Testing and Pap Test Market Size, Growth by Test Type (HPV Testing (Follow-Up HPV Testing, Co- Testing, Primary HPV Testing), PAP Test), End User (Laboratories, Hospitals, Physician’s Offices & Clinics), Region - Global Forecast to 2027", is projected to reach USD 9.2 billion by 2027, at a CAGR of 13.2%.
Browse 211 market data Tables and 35 Figures spread through 180 Pages and in-depth TOC on "HPV Testing and Pap Test Market - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/hpv-testing-pap-test-market-214207371.html
Development of new cervical cancer diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the HPV testing and Pap test market.
The HPV testing segment accounted for the largest share of the HPV testing and Pap test market, by test type segment.
Based on test type, the HPV testing and Pap test market is segmented into HPV Testing and Pap Test. The HPV testing segment accounted for the largest share of the HPV testing and Pap test market, mainly due to the growth of cervical cancer diagnostics products market.
The cervical cancer screening segment accounted for the largest share of the HPV testing and Pap test market, by test type segment
Based on application, the HPV testing and Pap test market is segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment accounted for the largest share of the HPV testing and Pap test market, mainly due to the growth of public awareness about cervical cancer.
Hospitals companies segment to register the highest growth rate during the forecast period
The HPV testing and Pap test market is segmented into laboratories, hospitals and physician’s offices & clinics based on end user. The hospitals segment accounted for the largest share of the HPV testing and Pap test market. The large share of this segment can mainly be attributed to the investment in the biotech and pharmaceutical industry.
North America is the largest regional market for HPV testing and Pap test market
The global HPV testing and Pap test market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for HPV testing and Pap test market. The large share of North America in this market can be attributed to the governments support for cancer research in the region.
The major players operating in this market are Abbott Laboratories (US), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (US), Hologic, Inc. (US), Quest Diagnostics (US), Qiagen N.V. (Netherland), Seegene, Inc. (US), Femasys, Inc. (US), Arbor Vita Corporation (US) and Mylab Discovery Solutions Pvt. Ltd. (India).
Development of new cervical cancer diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the HPV testing and Pap test market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the HPV Testing and Pap Test Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
